TAMPA, FLORIDA – September 3, 2020 – Legacy-Xspire Holdings, LLC (“Legacy”), a portfolio company of HealthEdge Investment Partners, LLC (“HealthEdge”) announced today that it has completed the acquisition of the US and Canadian distribution rights for ZONTIVITY® (Vorapaxar Sulfate) from New American Therapeutics, LLC.
Read More